Search Prime Grants

U54HD113142

Cooperative Agreement

Overview

Grant Description
Stanford PRIHSM: Preventing Inequities in Hemorrhage-Related Severe Maternal Morbidity - Project Summary:

Overall postpartum hemorrhage (PPH) is a leading cause of maternal death and severe maternal morbidity (SMM) and disproportionately affects socially marginalized groups. We propose to create a Maternal Health Research Center of Excellence at Stanford University called PRIHSM (Preventing Inequities in Hemorrhage-Related Severe Maternal Morbidity).

The goals of PRIHSM are to reduce PPH and associated SMM by reducing antenatal iron deficiency anemia (IDA), addressing disparities in rates of cesarean birth and cesarean-linked PPH, and attending to the impact of PPH on postpartum mental health.

IDA affects approximately 16% of pregnancies in the U.S.; rates are 3-4x higher among Black people and 1.5-2x higher among Latinx people, compared to the rest of the population. This translates to higher rates of PPH-related SMM. We propose that by effectively addressing antenatal IDA and these disparities, we can reduce PPH-related SMM.

Intrapartum exposures also play a major role in the risks and disparities associated with PPH. Almost 1 in 3 U.S. births are by cesarean delivery, rates vary 10-fold across hospitals, and Black and Asian individuals have the highest prevalence of cesarean section among low-risk pregnancies. We propose that enhanced birth equity and reduced variability in obstetric management are important strategies in addressing disparities in cesarean-linked PPH and reducing PPH-related SMM.

PPH may also dramatically alter the postpartum emotional life course. Prospective longitudinal research to understand mental health trajectories following PPH is needed, as are effective treatments. We propose an approach that is innovative in that it targets the unique clinical and mental health spectrum of PPH at multiple intervention points, through multi-disciplinary, community-engaged science.

Our aims are:

AIM 1 (Project 1). Reduce antenatal IDA by developing, implementing, and disseminating a patient-informed anemia prevention toolkit, which will standardize the evaluation, diagnosis, and treatment of IDA and reduce the prevalence of IDA and racial/ethnic disparities in IDA at birth admission and PPH-associated SMM.

AIM 2 (Project 2). Reduce disparities in rates of primary cesarean birth and cesarean-linked PPH by conducting a mixed methods study to understand drivers of hospital-level disparities in these outcomes, and implementing a patient-informed maternal equity guide.

AIM 3 (Project 3). Advance our understanding of PTSS following severe PPH by examining the course of PTSS following PPH, and implementing patient-informed PTSD treatment and prevention strategies.

Our work will involve community-university partnerships focused on improving maternal health equity and be driven by perspectives of patients, providers, and healthcare leadership. Our work will provide training opportunities to build research and clinical expertise relevant to PPH, especially among individuals who represent diverse perspectives and experiences within academic and community-based settings, and underserved areas.

We propose a bold yet achievable agenda that will affect a sustainable decline in PPH-related mortality and morbidity and disparities.
Funding Goals
NOT APPLICABLE
Place of Performance
Palo Alto, California 94304 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 124% from $1,870,026 to $4,188,473.
The Leland Stanford Junior University was awarded PRIHSM: Maternal Health Equity & PPH Reduction Cooperative Agreement U54HD113142 worth $4,188,473 from the National Institute of Child Health and Human Development in August 2023 with work to be completed primarily in Palo Alto California United States. The grant has a duration of 7 years and was awarded through assistance program 93.865 Child Health and Human Development Extramural Research. The Cooperative Agreement was awarded through grant opportunity Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 7/19/24

Period of Performance
8/17/23
Start Date
7/31/30
End Date
29.0% Complete

Funding Split
$4.2M
Federal Obligation
$0.0
Non-Federal Obligation
$4.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54HD113142

Subgrant Awards

Disclosed subgrants for U54HD113142

Transaction History

Modifications to U54HD113142

Additional Detail

Award ID FAIN
U54HD113142
SAI Number
U54HD113142-298510656
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NT00 NIH EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Funding Office
75NT00 NIH EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Awardee UEI
HJD6G4D6TJY5
Awardee CAGE
1KN27
Performance District
CA-16
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Child Health and Human Development, National Institutes of Health, Health and Human Services (075-0844) Health research and training Grants, subsidies, and contributions (41.0) $1,870,026 88%
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $250,000 12%
Modified: 7/19/24